# | Title | Journal | Year | Citations |
---|
1 | Functional Impairment in Children and Adolescents with Obsessive-Compulsive Disorder | Journal of Child and Adolescent Psychopharmacology | 2003 | 459 |
2 | Long-Term Safety and Efficacy of Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder | Journal of Child and Adolescent Psychopharmacology | 2009 | 288 |
3 | DSM-IV Mania Symptoms in a Prepubertal and Early Adolescent Bipolar Disorder Phenotype Compared to Attention-Deficit Hyperactive and Normal Controls | Journal of Child and Adolescent Psychopharmacology | 2002 | 287 |
4 | Alpha-2 Adrenergic Receptor Agonists for the Treatment of Attention-Deficit/Hyperactivity Disorder: Emerging Concepts from New Data | Journal of Child and Adolescent Psychopharmacology | 2007 | 286 |
5 | A Preliminary Study of the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children Mania Rating Scale for Children and Adolescents | Journal of Child and Adolescent Psychopharmacology | 2003 | 267 |
6 | Impairment in Childhood Anxiety Disorders: Preliminary Examination of the Child Anxiety Impact Scale–Parent Version | Journal of Child and Adolescent Psychopharmacology | 2004 | 254 |
7 | Safety and Effectiveness of Coadministration of Guanfacine Extended Release and Psychostimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder | Journal of Child and Adolescent Psychopharmacology | 2009 | 241 |
8 | Clinical Evaluation of Youth with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): Recommendations from the 2013 PANS Consensus Conference | Journal of Child and Adolescent Psychopharmacology | 2015 | 241 |
9 | The Presentation of Anxiety in Children with Pervasive Developmental Disorders | Journal of Child and Adolescent Psychopharmacology | 2005 | 234 |
10 | Weight Gain and Metabolic Risks Associated with Antipsychotic Medications in Children and Adolescents | Journal of Child and Adolescent Psychopharmacology | 2011 | 221 |
11 | Diagnostic Characteristics of 93 Cases of a Prepubertal and Early Adolescent Bipolar Disorder Phenotype by Gender, Puberty and Comorbid Attention Deficit Hyperactivity Disorder | Journal of Child and Adolescent Psychopharmacology | 2000 | 219 |
12 | Phenomenology of Prepubertal and Early Adolescent Bipolar Disorder: Examples of Elated Mood, Grandiose Behaviors, Decreased Need for Sleep, Racing Thoughts and Hypersexuality | Journal of Child and Adolescent Psychopharmacology | 2002 | 213 |
13 | A Review of Co-Morbid Depression in Pediatric ADHD: Etiologies, Phenomenology, and Treatment | Journal of Child and Adolescent Psychopharmacology | 2008 | 211 |
14 | Chronic Versus Episodic Irritability in Youth: ACommunity-Based, Longitudinal Study of Clinical and Diagnostic Associations | Journal of Child and Adolescent Psychopharmacology | 2006 | 210 |
15 | Attention-Deficit Hyperactivity Disorder Symptoms in a Clinic Sample of Children and Adolescents with Pervasive Developmental Disorders | Journal of Child and Adolescent Psychopharmacology | 2006 | 196 |
16 | A Prospective Open-Label Treatment Trial of Olanzapine Monotherapy in Children and Adolescents with Bipolar Disorder | Journal of Child and Adolescent Psychopharmacology | 2001 | 186 |
17 | Calming Effects of Deep Touch Pressure in Patients with Autistic Disorder, College Students, and Animals | Journal of Child and Adolescent Psychopharmacology | 1992 | 184 |
18 | ADouble-Blind Placebo-Controlled Pilot Study of Olanzapine in Childhood/Adolescent Pervasive Developmental Disorder | Journal of Child and Adolescent Psychopharmacology | 2006 | 171 |
19 | Medication Patterns in Patients with Autism: Temporal, Regional, and Demographic Influences | Journal of Child and Adolescent Psychopharmacology | 2005 | 170 |
20 | Increased Amygdala: Hippocampal Volume Ratios Associated with Severity of Anxiety in Pediatric Major Depression | Journal of Child and Adolescent Psychopharmacology | 2003 | 166 |
21 | Neurobiological Substrates of Tourette's Disorder | Journal of Child and Adolescent Psychopharmacology | 2010 | 166 |
22 | Medication Use Among Children with Autism Spectrum Disorders | Journal of Child and Adolescent Psychopharmacology | 2007 | 165 |
23 | Long-Term Administration of Intranasal Oxytocin Is a Safe and Promising Therapy for Early Adolescent Boys with Autism Spectrum Disorders | Journal of Child and Adolescent Psychopharmacology | 2013 | 165 |
24 | An Open-Label Trial of Riluzole, a Glutamate Antagonist, in Children with Treatment-Resistant Obsessive-Compulsive Disorder | Journal of Child and Adolescent Psychopharmacology | 2007 | 163 |
25 | Psychometric Properties of the Children's Depression Rating Scale–Revised in Adolescents | Journal of Child and Adolescent Psychopharmacology | 2010 | 162 |
26 | Behavioral Interventions for Anger, Irritability, and Aggression in Children and Adolescents | Journal of Child and Adolescent Psychopharmacology | 2016 | 162 |
27 | ADouble-Blind, Placebo-Controlled Study of Valproate for Aggression in Youth with Pervasive Developmental Disorders | Journal of Child and Adolescent Psychopharmacology | 2005 | 160 |
28 | Risperidone Effects in the Presence/Absence of Psychostimulant Medicine in Children with ADHD, Other Disruptive Behavior Disorders, and Subaverage IQ | Journal of Child and Adolescent Psychopharmacology | 2004 | 159 |
29 | Treatment-Emergent Adverse Events from Selective Serotonin Reuptake Inhibitors by Age Group: Children versus Adolescents | Journal of Child and Adolescent Psychopharmacology | 2006 | 159 |
30 | Impact of Comorbidity on Treatment Response to Paroxetine in Pediatric Obsessive-Compulsive Disorder: Is the Use of Exclusion Criteria Empirically Supported in Randomized Clinical Trials? | Journal of Child and Adolescent Psychopharmacology | 2003 | 156 |
31 | Proton Magnetic Resonance Spectroscopy of the Frontal Lobe and Cerebellar Vermis in Children with a Mood Disorder and a Familial Risk for Bipolar Disorders | Journal of Child and Adolescent Psychopharmacology | 2003 | 155 |
32 | Open-Label Quetiapine in the Treatment of Children and Adolescents with Autistic Disorder | Journal of Child and Adolescent Psychopharmacology | 1999 | 154 |
33 | Sertraline Treatment of Transition-Associated Anxiety and Agitation in Children with Autistic Disorder | Journal of Child and Adolescent Psychopharmacology | 1997 | 153 |
34 | Psychostimulant Treatment and Risk for Substance Abuse Among Young Adults with a History of Attention-Deficit/Hyperactivity Disorder: APopulation-Based, Birth Cohort Study | Journal of Child and Adolescent Psychopharmacology | 2005 | 153 |
35 | Efficacy of Modafinil Compared to Dextroamphetamine for the Treatment of Attention Deficit Hyperactivity Disorder in Adults | Journal of Child and Adolescent Psychopharmacology | 2000 | 151 |
36 | Acute and Long-Term Safety and Tolerability of Risperidone in Children with Autism | Journal of Child and Adolescent Psychopharmacology | 2005 | 147 |
37 | The Neurobiology of Impulsive Aggression | Journal of Child and Adolescent Psychopharmacology | 2016 | 147 |
38 | Early Methylphenidate Administration to Young Rats Causes a Persistent Reduction in the Density of Striatal Dopamine Transporters | Journal of Child and Adolescent Psychopharmacology | 2001 | 140 |
39 | The Immunobiology of Tourette's Disorder, Pediatric Autoimmune Neuropsychiatric Disorders Associated withStreptococcus, and Related Disorders: A Way Forward | Journal of Child and Adolescent Psychopharmacology | 2010 | 138 |
40 | Fluoxetine and Methylphenidate in Combination for Treatment of Attention Deficit Disorder and Comorbid Depressive Disorder | Journal of Child and Adolescent Psychopharmacology | 1993 | 137 |
41 | Diagnosis and Measurement of Adolescent Depression: A Review of Commonly Utilized Instruments | Journal of Child and Adolescent Psychopharmacology | 2001 | 136 |
42 | Effect of CX516, an AMPA-Modulating Compound, on Cognition and Behavior in Fragile X Syndrome: AControlled Trial | Journal of Child and Adolescent Psychopharmacology | 2006 | 136 |
43 | Risperidone in Preschool Children with Autistic Spectrum Disorders: An Investigation of Safety and Efficacy | Journal of Child and Adolescent Psychopharmacology | 2006 | 136 |
44 | Unravelling Sleep Problems in Treated and Untreated Children with ADHD | Journal of Child and Adolescent Psychopharmacology | 1999 | 134 |
45 | An Open-Label, Dose-Ranging Study of Atomoxetine in Children with Attention Deficit Hyperactivity Disorder | Journal of Child and Adolescent Psychopharmacology | 2001 | 134 |
46 | Autism Spectrum Traits in Children with Mood and Anxiety Disorders | Journal of Child and Adolescent Psychopharmacology | 2005 | 134 |
47 | A Naturalistic Open-Label Study of Mirtazapine in Autistic and Other Pervasive Developmental Disorders | Journal of Child and Adolescent Psychopharmacology | 2001 | 133 |
48 | Response to Methylphenidate in Children with Attention Deficit Hyperactivity Disorder and Manic Symptoms in the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder Titration Trial | Journal of Child and Adolescent Psychopharmacology | 2003 | 132 |
49 | Second-Generation Antipsychotic Medications in Children and Adolescents | Journal of Child and Adolescent Psychopharmacology | 2004 | 132 |
50 | Effectiveness of Melatonin in the Treatment of Sleep Disturbances in Children with Asperger Disorder | Journal of Child and Adolescent Psychopharmacology | 2003 | 129 |